Zorion Medical, Inc.

The cardiology sector has long been one of the most innovative in medtech, with technologies such as drug-eluting stents (DES) and transcatheter aortic valves cutting down the need for more invasive o

Abbott Laboratories Inc. ’s Absorb everolimus-eluting bioresorbable vascular scaffold( BVS ) remains on track for a late-2015 PMA submission based on data showing the novel device performed at lea

In Vitro Diagnostics Biocartis SA Series C generates €71mm for Biocartis Four-year-old Swiss molecular diagnostics company Biocartis NV has raised €71mm ($96mm) in its Series C financing led by